Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies

CONCLUSION: Diagnostic modalities along with biomarker and genetic testing could detect disease earlier and target therapy more accurately. Novel therapies demonstrate potential treatment benefits and can help shape the standard of care for these patients.PMID:33685242 | DOI:10.1177/10600280211000351

Source: The Annals of Pharmacotherapy - March 9, 2021 Category: Drugs & Pharmacology Authors: Jankhna D Yadav Harjot Othee Kelly A Chan Damen C Man Paul P Belliveau Jennifer Towle Source Type: research